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Background: Trauma throughout the lifespan is associated with adverse health outcomes, 
potentially via inflammatory processes. Traumatic experiences in both childhood and adulthood 
are related to increased levels of inflammation. However, more work is needed to investigate how 
trauma relates to inflammation over time and to test how traumatic experiences in childhood and 
adulthood independently or collectively relate to adult inflammation.  
Methods: This study tested relations between child maltreatment, lifetime trauma, and 
inflammation in a cohort of 298 peri and postmenopausal women aged 40-60. Participants were 
invited back 5 years later to participate in the ongoing follow-up study (n=170). Measures of child 
maltreatment, lifetime trauma, demographics, and a fasting blood draw were collected. Multiple 
regression analyses were conducted testing associations between child and adult trauma in relation 
to inflammation controlling for demographics, body mass index, and immune medication both 
cross sectionally and longitudinally. Moderation effects were modeled by interaction terms and 
tests for mediation utilized bootstrapping.  
Results: 44% of women (N=132) reported some form of maltreatment and 60% of women 
(N=178) reported some form of lifetime trauma. At baseline, a history of child emotional abuse or 
physical neglect was associated with higher levels of IL-6 [emotional abuse: b(SE)=0.12(0.05), 
p=.046; physical neglect: b(SE)=0.12(0.06), p=.02]. At follow-up, a history of being in a natural 
disaster was associated with higher levels of CRP, while a history of being physically attacked was 
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associated with lower levels of TNF- α [natural disaster: b(SE)=0.29(0.12), p=.04; physical attack: 
b(SE)=-0.37(0.10), p=.0002]. In longitudinal analyses, a history of being in a natural disaster was 
associated with a greater increase in IL-6 over time and experiencing the death of a child was 
associated with a greater increase in CRP over time [natural disaster: b(SE)=0.19(0.07), p=.007; 
death of a child: b(SE)=0.34(0.13), p=.009]. Analyses did not support independent, interactive, or 
explanatory relationships between child maltreatment, lifetime trauma, and inflammation either 
cross sectionally or longitudinally. 
Conclusion: Trauma throughout the lifespan was prevalent in this sample of midlife 
women. Associations between childhood maltreatment, lifetime trauma, and inflammation were 
observed for specific subtypes of maltreatment or trauma, but were not consistent across time or 
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1.1 Childhood Maltreatment and Later Risk for Disease 
Multiple studies have found an association between childhood maltreatment and a range of 
adverse health outcomes in adulthood. For example, the Adverse Childhood Experiences (ACE) 
Study conducted amongst a large cohort in the Kaiser Permanente healthcare system found a 
graded relationship between the number of retrospectively-reported childhood adverse experiences 
(including abuse/neglect) and risk for ischemic heart disease, cancer, chronic lung disease, skeletal 
fractures, and liver disease.1 Women in the Nurses’ Health Study II who retrospectively reported 
childhood abuse utilizing a validated questionnaire, had increased risk for diabetes and 
hypertension.2,3 Further, a meta-analytic review of over 48,000 individuals found that childhood 
physical, sexual, emotional abuse and/or neglect was associated with increased risk for or severity 
of cardiovascular disease, respiratory or gastrointestinal problems, diabetes and obesity, 
gynecological problems, neurological problems, and/or musculoskeletal problems with a small to 
medium effect size.4 Another meta-analysis exploring the relationship between childhood sexual 
abuse and adult physical health outcomes found that those with a history of childhood sexual abuse 
were more likely to endorse poor health outcomes such as cardiopulmonary, gastrointestinal, 
gynecologic symptoms, and obesity, with a small to medium effect size.5 Taken together, these 
studies indicate a relationship between childhood maltreatment and worse adult physical health. 
The pathways between childhood maltreatment and later adverse health outcomes are 
likely many. Previous studies have proposed behavioral mechanisms such as substance abuse, 
obesity, high risk sexual behavior, smoking, and/or sleep difficulties.6–8 Given the relationship 
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between childhood maltreatment and disorders such as depression and post-traumatic stress 
disorder (PTSD), emotional factors have also been proposed as a pathway between maltreatment 
and later adult health.6–8 Indeed, a population study found that health behaviors such as smoking, 
poor nutrition, high alcohol consumption, and higher-risk sexual practices as well as a history of 
anxiety, depression, bipolar disorder, or bulimia partially mediated the relationship between 
childhood abuse and indicators of adult physical health.9  In addition, a combination of cognitive 
and social factors have been proposed as potential pathways between childhood maltreatment and 
adult health. For example, research proposes that those exposed to childhood maltreatment may 
be especially vigilant of threat, mistrusting of others, and possess a chronically negative 
worldview, which may lead to dysfunctional interpersonal styles, more conflict, less social 
support, and in turn worse physical health outcomes.6,10  
Lastly, studies have proposed that childhood maltreatment induces a range of biological 
changes during childhood that can be observed into adulthood, such as a smaller prefrontal cortex 
and hippocampus volume, lower basal cortisol levels, an elevated adrenocorticotropic hormone 
response to psychological stressors, and changes in endothelial function and insulin resistance, that 
may explain the relationship between childhood maltreatment and later disease.7,11–13 Research 
also indicates that inflammatory processes may play a significant role in the relationship between 
childhood maltreatment and later disease risk. It is proposed that childhood maltreatment is related 
to small and sustained increases of circulating markers of inflammation.14 These small increases 
in circulating levels of inflammation in healthy populations are predictive of later disease risk.15 
Given its well-established links to a diverse set of disease processes,16–18 it may be of particular 




1.2 The Immune System and Inflammation as a Predictor of Later Disease Risk 
The primary function of the immune system is to maintain homeostasis by preventing or 
limiting infection. Besides physical barriers such as skin and mucosal membranes, the immune 
system is comprised of two main branches; the innate and the adaptive immune systems. Both 
systems utilize structural features on cells to differentiate between foreign particles and cells 
endogenous to the self. The innate system responds quickly to commonly recognized 
bacteria/viruses and utilizes white blood cells such as macrophages, neutrophils, and natural killer 
cells. The adaptive immune system utilizes its “immune memory” to respond quickly and 
effectively to previously encountered pathogens by upregulating the activity of B or T cells.19 
These two systems act in concert; The innate system collects and integrates information that directs 
the adaptive immune system on details of the immune response such as the location of the immune 
challenge and what cell types to utilize. One of the ways that these two systems communicate is 
through immune modulators called cytokines, which act as signaling molecules.19 
1.2.1 Immune Modulators  
In addition to facilitating communication between the innate and adaptive immune system, 
cytokines are involved in a host of immunomodulatory activities. As a part of the innate immune 
system, activated phagocytic cells such as macrophages release proinflammatory cytokines that 
amplify the immune response by recruiting other cells to the site of the immune challenge. In 
addition to activating or modulating the immune response, a subtype of cytokines known as anti-
inflammatory cytokines can inhibit the immune system. These anti-inflammatory mediators slow 
the inflammatory cascade by binding to receptors on immune cells to reduce cell proliferation rate 
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or by blocking the stimulatory signals of other cytokines. Thus, cytokines play an active and varied 
role in inflammatory processes.19 
Research on psychosocial factors and immune function often consider immune modulators 
important to the inflammatory cascade of the innate immune system, including tumor necrosis 
factor-alpha (TNF-α) and interleukin-6 (IL-6). TNF-α, produced by activated macrophages, is one 
of the principle mediators that facilitates the host response to immune challenges as part of the 
innate immune system. Locally, TNF-α increases the adhesion of leukocytes to the site of immune 
challenge by increasing the expression of adhesion molecules on the endothelium. TNF-α also 
enters the blood to enhance the production of immune cells such as neutrophils in the bone marrow. 
Further, TNF-α can stimulate phagocytes to produce other cytokines such as interleukin-1 (IL-1) 
and to secrete IL-6 into circulation.20 In clinical studies, small increases in circulating levels of 
TNF-α, thought to reflect systemic levels of inflammation, have been linked to inflammatory 
diseases such as arthritis, inflammatory bowel disease,21 as well as cardiovascular disease,22 and 
cancer.23  
IL-6 is a cytokine that has both local and systemic effects as part of the innate inflammatory 
cascade. IL-6 is synthesized by mononuclear phagocytes, by vascular endothelial cells, and in 
response from TNF-α. IL-6 induces the synthesis of a subtype of plasma proteins called acute 
phase reactants and enhances the production of neutrophils in the bone marrow.20 In clinical 
studies, elevated levels of IL-6 have been associated with diseases such as arthritis,24 
cardiovascular disease events,25 and type II diabetes.26 In some situations, IL-6 is produced by T 
cells and serves an anti-inflammatory function; however, circulating levels are more often 
considered a measure of systemic inflammation.  
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In addition to proinflammatory cytokines, circulating levels of another immune modulator, 
acute phase proteins, are also measured as a marker of systemic levels of inflammation. The acute 
phase response is the rapid rise of plasma protein levels in response to injury or infection. C-
reactive protein (CRP) is a widely-measured acute phase protein that is released in response to the 
stimulation of hepatocytes by IL-6, IL-1 and TNF-α.27 CRP initiates the classical component 
pathway which detects and binds to microbes and activates a cascade that promotes the 
phagocytosis of the microbes.20 CRP levels are known to be elevated in diseases of chronic 
inflammation such as rheumatoid arthritis and in cardiovascular disease.15,28  
1.2.2 Levels of Inflammation Predictive of Later Disease 
While large increases in circulating levels of cytokines reflect acute infection or clinical 
disease, small and sustained increases of circulating markers of inflammation that are in the 
physiologically normal range are predictive of later disease risk.29 For instance, small and/or 
sustained increases in proinflammatory biomarkers (conceptualized as heightened levels of 
systemic inflammation) have been related to diseases such as autoimmune disorders, as well as 
type II diabetes, and cardiovascular disease.15,30,31 The mechanisms by which these small increases 
in circulating levels of immune markers predict future disease risk are likely many. Increases could 
reflect lifestyle factors, genetics, or the cumulative wear and tear of subclinical inflammatory 
processes, such as atherosclerosis.32–34 Thus, small sustained increases in systemic inflammation, 
such as that which may be observed with psychosocial stressors, may have implications for health.  
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1.3 Childhood Maltreatment and Inflammation 
Previous findings indicate a link between childhood maltreatment recalled in adulthood 
and circulating markers of inflammation in adulthood. A study of healthy older adults, half of 
whom were dementia family caregivers and half of whom were non-caregivers, found that those 
with a history of childhood abuse exhibited heightened IL-6 and TNF-α compared to older adults 
without this history. These results were not explained by factors such as age, caregiving status, 
gender, body mass index (BMI), exercise, and sleep.35 Furthermore, a history of sexual and 
emotional abuse, emotional and physical neglect, and the total number of types of abuse were 
associated with higher CRP levels in the Study of Women’s Health Across the Nation (SWAN), a 
cohort of mid-life women.36 This relationship persisted after adjusting for ethnicity, education, 
smoking status, hormone therapy, depression symptoms, and blood pressure medication, but was 
attenuated after adjusting for BMI. In a sample from the Midlife in the United States (MIDUS) 
study, early life adversity was associated with increased IL-6, but not CRP among African 
Americans, while there was no relationship between adversity and any inflammatory marker 
among Whites. This relationship was attenuated when controlling for covariates BMI, smoking 
status, and exercise levels.37  
In contrast to childhood abuse recalled in adulthood, several studies have examined the 
relationship between prospectively reported childhood maltreatment and adult inflammation. A 
study utilizing longitudinal data from the Avon Study of Parents and Children found that adverse 
events from birth to age 8 were associated with higher levels of IL-6 at age 10 and higher levels 
of CRP at ages 10 and 15 when adjusting for gender, age, ethnicity, family income, mother’s 
education, and medication use.38 The associations between cumulative adverse events and levels 
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of IL-6 and CRP were mediated by BMI. In a longitudinal study of the Dunedin cohort, childhood 
maltreatment was associated with higher CRP levels in a dose-response relationship 20 years later 
even after adjusting for childhood risk factors, adult SES, depression, high perceived stress, 
cardiovascular disease risk cluster (which included being overweight), and health behaviors.39 
Thus, several studies have found an association between reports of childhood maltreatment and 
later inflammation, while also highlighting the importance of considering adiposity and behavioral 
factors in this relationship. 
Several reviews and meta-analyses have examined the relationship between childhood 
maltreatment and inflammation. A 2016 meta-analysis found that individuals with a history of 
childhood maltreatment demonstrated elevated levels of inflammation with small effect sizes for 
CRP, IL-6, and TNF-α.40 However, this meta-analysis noted that associations between trauma and 
inflammation were heterogeneous among studies, potentially because of marked differences in 
immune marker and childhood trauma measurement, and inconsistent exclusion criteria based on 
acute illness. In addition, there were larger effect sizes in the relationship between trauma and 
inflammation for studies that utilized validated measures of childhood trauma.40 A systematic 
review of the relationship between childhood maltreatment and adult levels of circulating markers 
of inflammation among clinical samples found that childhood maltreatment was most consistently 
associated with higher levels of CRP, with more mixed results for IL-6 or TNF-α. Further, this 
review noted that many studies had a low number of subjects with history of childhood 
maltreatment and that studies were again heterogeneous in childhood maltreatment assessment and 
definition.14  
Research typically utilizes retrospective self-report questions about the presence or absence 
of various types of abuse/neglect. While retrospective reports have advantages such as 
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convenience, low cost, and utility in adult populations, individuals tend to underreport childhood 
maltreatment, and infrequently these reports may include false positives.41 Prospective reports of 
childhood maltreatment by family members or by the children themselves have advantages such 
as avoiding memory biases. However, parental reports of maltreatment increase the possibility that 
if the parent is the perpetrator, some forms of abuse/neglect may be underreported.41 The rigor of 
official reports to government agencies (including an initial report, an investigation, and a 
substantiation decision) reduces the possibility of false positives.42 However, whether abuse is 
reported depends on a range of factors such as severity of abuse, socioeconomic status (SES), and 
race,43 and these reports often greatly underrepresent the amount of actual maltreatment in the 
population.44 Regardless of whether a study utilizes retrospective, prospective, or official reports 
of childhood maltreatment, it is important to clearly define the form of maltreatment being queried 
and to ask multiple specific questions about each form of maltreatement.41 
Thus, while research indicates that there is a relationship between childhood maltreatment 
and heightened markers of inflammation, several questions remain. For example, while some 
studies utilized validated scales of childhood maltreatment,35,36 others used non-
standardized/validated measurements,37,39 which may result in underestimates of certain subtypes 
of abuse.38 While the relationship between childhood maltreatment and heightened levels of 
circulating inflammation was independent of BMI or weight in some samples,35,39 this relationship 
was mediated by BMI in other studies.36–38 Further, previous studies have not consistently 
excluded based on acute illness, which may lead to heterogeneity among studies.40 Thus, there is 
a need for future studies to utilize validated measures of abuse and neglect and to consider the 




There are several potential mechanisms that may link trauma to inflammation. Childhood 
maltreatment is associated with sympathetic nervous system dysregulation,45 which may lead to 
changes in levels of inflammatory markers via the reciprocal innervation of primary and secondary 
lymphoid tissue which partake in immune processes.46 In addition, chronic stress is associated with 
marked changes in the HPA axis,47 and lower levels of anti-inflammatory glucocorticoids may 
lead to higher levels of systemic inflammation.48 Trauma throughout the lifespan has also been 
associated with increased alcohol consumption, greater levels of adipose tissue, and depressive 
disorders later in life,49–51 which could also explain the relationship between trauma and changes 
in levels of inflammation.32,52–54 
1.4 Lifetime Trauma and Inflammation 
In addition to an association between trauma that happened during childhood and later 
inflammation, research indicates that a traumatic event that occurred anywhere in the lifespan, 
including adulthood, is associated with increases in circulating markers of inflammation. In a small 
community sample, women who experienced rape in the past 72 hours demonstrated significantly 
elevated levels of CRP, interleukin-10 (IL-10), and IL-6 as compared to women in the control 
group.55 In a sample of older female primary care patients, lifetime history of sudden loss of a 
loved one was associated with higher levels of IL-6 even after adjusting for race, age, education, 
income, depression and obesity. There was a linear relationship between ordered categories of 
lifetime loss (0, 1, 2-5, 5+) and increases in IL-6.56 A study of participants in the Heart and Soul 
cohort with stable cardiovascular disease found that higher lifetime levels of a range of trauma 
exposures (i.e. sexual/physical assault, serious accidents, or the death of a loved one) were related 
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to increased levels of a composite score of proinflammatory markers of inflammation (including 
IL6, TNF-α, CRP, and resistin) at baseline and 5 years later even when adjusting for age, gender, 
education, psychiatric and medical comorbidities. However, the relationship between higher 
lifetime trauma exposure and the composite proinflammatory score 5 years later was attenuated 
when adjusting for tobacco, drug use, and sleep quality.57 A 2014 meta-analysis considered the 
association between trauma exposure throughout the lifespan (including childhood adversity) and 
proinflammatory markers in adulthood and found that trauma exposure was significantly 
associated with higher levels of CRP) interleukin-1beta (IL-1β), IL-6, and TNF-α all of moderate 
to large correlations.58 The meta-analysis noted that the relationship between trauma and 
inflammation was especially pronounced in clinical vs non-clinical samples and that the inclusion 
of relevant covariates was related to heterogeneity in effect sizes.  
Indeed, previous research has not consistently considered relevant confounders such as 
BMI or depressive symptoms,55,58 has focused on specific traumas,55,56,59 and/or has been 
conducted among small samples.55,56,59 Thus, while research indicates that trauma throughout the 
lifespan is associated with increased levels of inflammation, there is a need for larger studies of 
non-clinical samples with well-characterized demographic, psychological, and health factors that 
consider a wide range of traumatic experiences. Further, while research indicates that there are 
independent relationships between childhood maltreatment, lifetime traumatic experiences and 
inflammation, less is known about the potential independent, interactive, or synergistic effects of 
childhood maltreatment and lifetime traumas on later inflammation. 
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1.5 Childhood Maltreatment, Lifetime Trauma, and Inflammation 
We will consider three models detailing how childhood maltreatment and lifetime trauma 
may collectively relate to adult inflammation: the stress sensitization model, the stress generation 
model, and the stress accumulation model (see Figure 1). 
1.5.1 Stress Sensitization Model 
The stress sensitization model hypothesizes that early life is a sensitive developmental 
period and that childhood trauma may shape reactions to stressors later in life such that those with 
a history of childhood maltreatment will demonstrate amplified biological responses to adverse 
life events. Research indicates that childhood trauma, but not adult trauma, is associated with 
increased transcription of proinflammatory genes later in life.60 Further, it was found that adults 
with a history of maltreatment exhibit low basal cortisol levels and an elevated adrenocorticotropic 
hormone response to psychological stressors.11 Thus, it is posited that childhood maltreatment will 
have long lasting effects on stress response systems and that it will synergistically amplify 
reactions to later life stress. 
Most studies examining the relationship between childhood maltreatment, lifetime trauma, 
and inflammation have found support for the stress-sensitization model. One study examining the 
relationship between childhood adversity, adult stressors, and inflammation in a diverse sample of 
young adults found that childhood adversity and adult stressors were independently associated 
with a composite inflammation score of pro- and anti-inflammatory immune markers. Further, 
there was a significant interaction between childhood adversity and adult stressors such that those 
with both child trauma and adult stressors exhibited heightened levels of inflammation.61 A study 
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conducted in a sample of older adult caregivers found that a history of childhood abuse and 
multiple daily life stressors were independently associated with greater levels of IL-6. There was 
a significant interaction between childhood abuse history and daily stressors such that those with 
a history of childhood abuse had larger IL-6 responses to multiple daily stressors.62 However, a 
study conducted in a large population-based sample found that a history of childhood adversity 
and adult trauma were independently associated with higher levels of CRP, but that there was not 
a significant interaction between childhood adversity and adult trauma on levels of CRP.63 Thus, 
while there is evidence supporting the stress-sensitization model, findings are not entirely 
consistent. 
1.5.2 Stress Generation Model 
The stress generation model of the relationship between childhood abuse and lifetime 
traumatic experiences hypothesizes that childhood stress predisposes people to experience more 
stressful experiences later in life. It is posited that later psychosocial stressors, rather than the 
childhood maltreatment itself, is what is related later health in adulthood.64 Indeed, a previous 
study examining potential mediators of the relationship between childhood maltreatment and poor 
adult physical health found that adverse life events in adulthood accounted for 25% of the 
association between childhood maltreatment and chronic medical conditions.65 Further, 
individuals who have experienced child maltreatment are at increased risk for revictimization in 
adulthood. A prospective cohort study of almost 900 individuals found that those who experienced 
childhood maltreatment reported a higher number of traumas and victimization experiences than 
controls when interviewed approximately 30 years later.66 Although the pathways between 
victimization in childhood and revictimization in adulthood are likely many, childhood adversity 
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is associated with emotional dysregulation and engagement in risky behaviors.67 Further, 
childhood adversity tends to correlate with lower SES in the general population,68 potentially 
subjecting the individual to a harsh environment. Thus, the environmental correlates and emotional 
sequela of childhood adversity may predispose individuals to experience more frequent traumatic 
adult life experiences, which may account for the relationship between childhood maltreatment 
and later inflammation.  
A handful of studies have tested the stress generation model of the relationship between 
childhood maltreatment, lifetime traumatic experiences, and inflammation. In a sample from the 
MIDUS study, the relationship between early life adversity and increased levels of circulating IL-
6 was attenuated when controlling for adult stressors. However, adult stressors were not 
significantly related to levels of IL-6.37 In addition, a prospective study of the Dunedin cohort 
found that the relationship between early life adversity and increased levels of circulating CRP 
was not explained by stress experienced in adulthood.39 Thus far, there has been no evidence 
supporting the stress generation model of the relationship between childhood maltreatment, 
lifetime trauma, and inflammation. 
1.5.3 Stress Accumulation Model 
The stress accumulation model posits that childhood adversity and lifetime trauma have 
independent influences on inflammation.69 Previous research has established independent 
associations between childhood adversity and inflammation as well as lifetime traumatic 
experiences and inflammation.14,58 Further, research suggests a graded relationship between 
childhood adversity and mental or physical health outcomes such that the greater number of 
categories of adversity were associated with a heightened risk for adverse outcomes.1,70 Thus, the 
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stress accumulation model posits that a greater number of stressors throughout the lifespan will 
have independent and cumulative physiologic implications.  
 Many of the studies investigating the relationship between childhood maltreatment, 
lifetime trauma, and inflammation specifically examine the stress sensitization hypothesis and do 
not formally test for or discuss other models of the relationship between childhood adversity and 
lifetime trauma. However, one previous study specifically examines the relationship between 
childhood adversity, lifetime trauma, and inflammation by testing the stress sensitization, stress 
generation, and stress accumulation model. This study was conducted in a sample of 1180 middle-
aged and older adults from the MIDUS study and found that childhood adversity and adult stressors 
were independently associated with a pro-inflammatory composite score (IL-6, CRP, fibrinogen, 
E-selectin, and intercellular adhesion molecule-1) and that the interaction between childhood 
adversity and adult stressors was not significant, supporting the stress accumulation model.71 
1.6 Present Study 
In the present study, we propose to test three models of the relationship between child 
maltreatment, lifetime trauma, and inflammation in women whose markers of inflammation (IL-6 
and CRP) were characterized at two time points over midlife. This study will utilize a validated 
measure of childhood abuse or neglect, the Child Trauma Questionnaire, which has additional 
favorable characteristics such as assessing multiple types of trauma and reporting stronger 
psychometric properties compared to other self-report measures.72 In addition, we will consider 
multiple demographic, behavioral, psychological, and health confounders. Further, this study will 
examine this relationship in women, who experience higher rates of specific subtypes of abuse,73,74 
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and for whom midlife represents a period of hormonal change and physiologic vulnerability.75–77 
In exploratory analyses, we will examine specific subtypes of abuse as well as relations between 
abuse, trauma, and additional inflammatory markers collected at a single time point (TNF-α and 
IL-10). This study will be the first to rigorously test three competing models of the relationship 
between child maltreatment, lifetime trauma, and inflammation in women whose markers of 
inflammation were characterized over midlife. We will test the following aims:  
Aim 1: Is childhood maltreatment associated with higher levels of inflammatory markers 
over midlife in women? We hypothesize that women with a history of childhood maltreatment will 
show higher levels of CRP and IL-6 and greater increases in CRP and IL-6 over midlife as 
compared to those without this history.  
Aim 2: Are lifetime traumatic life events associated with higher levels of inflammatory 
markers over midlife in women? We hypothesize that women with a history of lifetime traumatic 
experiences will have higher levels of CRP and IL-6 and greater increases in CRP and IL-6 over 
midlife as compared to those without this history. 
Aim 3: What role does lifetime traumatic experiences play (i.e. independent, interactive) 
in the relationship between child maltreatment and inflammation? We hypothesize that there will 
be an interaction between childhood maltreatment and lifetime traumatic life events in relation to 
levels of inflammation over time, such that the association between traumatic life events and higher 
levels of as well as greatest increases in inflammation over time will be most pronounced among 
individuals with a history of childhood maltreatment.  
Exploratory aim: We will examine whether specific subtypes of abuse (sexual, physical, 
emotional abuse, physical, and/or emotional neglect) or lifetime traumatic events (serious accident, 
natural disaster, serious illness, being attacked, unwanted sexual contact, death of a child, sexual 
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harassment) are related to markers of inflammation in exploratory analyses. Further, we will 
explore the relationship between childhood maltreatment, lifetime trauma, and IL-10 and TNF-α, 
which were collected at a single time point. 
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2.0 Research Design and Methods 
2.1 Participants 
This study was conducted among participants of the MsHeart Study, a study originally 
designed to investigate the relation between menopausal vasomotor symptoms and cardiovascular 
health.77 MsHeart enrollment was conducted between January 2012 and May 2015 and included 
307 nonsmoking, late peri- and post-menopausal women aged 40 to 60. Approximately half of the 
sample reported daily vasomotor symptoms (n=153) while the other half reported no vasomotor 
symptoms in the prior three months (n=154). Participants have been invited back 5 years later to 
participate in the MsBrain study, a study designed to investigate the relation between vasomotor 
symptoms and brain health. MsBrain recruitment is ongoing and expected that 230 women, aged 
45-67 will complete the protocol by March 2021. For MsBrain, it is anticipated that 170 women 
from the MsHeart cohort will return, and recruitment from the community will be conducted to 
recruit the additional 60 women to reach a full MsBrain sample of 230 women. Thus, among 170 
women, MsHeart and MsBrain collectively comprise two waves of a longitudinal study.  
MsHeart exclusion criteria included hysterectomy and/or bilateral oophorectomy; a 
reported history of heart disease, stroke, arrhythmia, gynecological cancer, pheochromocytoma, 
pancreatic tumor, kidney failure, seizures, Parkinson disease, or Raynaud phenomenon; current 
pregnancy; or having used the following medications (due to their impact on key study measures) 
within the past 3 months: estrogen or progesterone, selective estrogen receptor modulators, 
selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, gabapentin, 
insulin, beta-blockers, calcium channel blockers, alpha-2 adrenergic agonists, other antiarrhythmic 
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agents. Women who had undergone endometrial ablation, endarterectomy, or lymph node removal 
or who were undergoing chemotherapy, hemodialysis, or peritoneal dialysis were excluded.77 
MsBrain exclusion criteria were a reported history of stroke or cerebral vascular accident, brain 
injury, dementia, Parkinson’s disease, carotid stent, active substance use, or current pregnancy; or 
having used the following medications (due to their impact on key study measures) within the past 
3 months: exogenous estrogen or progesterone, selective estrogen receptor modulators, selective 
serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, or aromatase 
inhibitors.  
At baseline (MsHeart), up to eight women were excluded due to missing abuse/neglect data 
depending on the subscale (physical neglect: n=1 to sexual abuse: n=8), one woman was excluded 
due to missing lifetime trauma information (death of a child: n=1), and three people were excluded 
due to missing inflammation data (CRP: n=3). Nine women were excluded due to a history of 
inflammatory medical disorders or use of immunosuppressive medications and nineteen women 
were excluded due to CRP values greater than 10 mg/L. Thus, at baseline final sample sizes ranged 
from N=268 to N=298. At follow-up (MsBrain), up to five women were excluded due to missing 
abuse/neglect data depending on the subscale (physical neglect: n=1 to sexual abuse: n=5), up to 
three woman was excluded due to missing lifetime trauma information (death of a child: n=1 to 
witnessing a traumatic event: n=3), and up to three people were excluded due to missing 
inflammation data (CRP: n=2 to IL-6: n=3). Twenty-two women were excluded due to a history 
of inflammatory medical disorders or use of immunosuppressive medications and 16 women were 
excluded due to CRP values greater than 10 mg/L. At follow-up, final sample sizes ranged from 
N=121 to N=148. Women were not excluded from analyses due to missing covariate data at either 
time point. At baseline, women excluded from analyses were more likely to be non-white [𝜒𝜒2 (1, 
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N=298) =14.28 p<.001] and on average had higher BMIs [t(46)=-3.15, p<0.01]. At follow-up, 
women excluded from analyses on average had higher BMIs [t(31)=-2.76, p<0.01]. 
2.2 Designs and Procedures 
At both study waves, participants underwent a telephone and in person screening, and 
completed physical measurements (e.g., height, weight, blood pressure), a fasting blood draw, and 
psychosocial questionnaires. Procedures were approved by the University of Pittsburgh 
Institutional Review Board. Participants provided written informed consent.  
2.3 Measures 
2.3.1 Child Trauma Questionnaire 
The Child Trauma Questionnaire was completed at baseline. The Child Trauma 
Questionnaire is a validated 28 item self-report measure that assesses child abuse and neglect.78 
Examples of questions include “People in my family said hurtful or insulting things to me” and “I 
got hit so hard by someone in my family that I had to see a doctor or go to the hospital”. Item 
scores range from 0 (never true) to 5 (very often true). The Child Trauma Questionnaire includes 
five subscales (sexual abuse, physical abuse, emotional abuse, physical neglect, and emotional 
neglect). Child Trauma Questionnaire short form has validated clinical cut off points.79 Scoring at 
or above 8 on the sexual abuse subscale, 8 on the physical abuse subscale, 10 on the emotional 
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abuse subscale, 8 on the physical neglect subscale, or 15 on the emotional neglect subscale 
indicates an instance of abuse/neglect. If a participant scored at or above any clinical threshold for 
one or more subscale, the participant was classified as having been exposed to any childhood 
maltreatment. The participant was considered as not exposed to childhood maltreatment if a 
participant scored below clinical thresholds on all abuse/neglect subscales. 
2.3.2 The Brief Trauma Questionnaire 
The Brief Trauma Questionnaire was completed at both time points. This questionnaire 
was adapted from the Brief Trauma Interview80,81 for the Nurse’s Health Study II.82 This 9 item 
self-report measure assesses a history of traumatic events. Participants can respond yes or no to 
having experienced any of the following events in their lifetime: serious accident, natural or human 
disaster, serious or life-threatening illness, physical attacks, unwanted sexual contact, death of a 
child, sexual harassment, any other situation in which you were seriously injured or feared serious 
injury, or witnessing a severe injury or death. If a participant endorsed experiencing any of the 
subtypes of traumatic events, they were classified as having been exposed to any lifetime trauma. 
2.3.3 Immune Markers 
Phlebotomy was performed at both time points after a 12-hr overnight fast. All women 
were free of acute illness (e.g. colds) when blood was drawn. At baseline, phlebotomy was 
performed at the Health Studies Research Center, Department of Epidemiology, University of 
Pittsburgh and assays were performed by the Chemistry and Nutrition Laboratory, Graduate 
School of Public Health, University of Pittsburgh. High sensitivity CRP was measured using a 
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high sensitivity (hs-CRP) reagent set (Beckman Coulter, Brea, CA). IL-6 was measured with an 
R&D Systems (Minneapolis, MN; Cat # HS600) high sensitivity kit. At follow-up, phlebotomy 
was performed at the University of Pittsburgh Women’s Biobehavioral Health Laboratory and 
assays were performed by the Clinical Ligand Assay Service Satellite lab, School of Public Health, 
Department of Epidemiology, University of Michigan. IL-6 was measured using a high sensitivity 
R&D Systems Quantikine Human IL-6 ELISA immunoassay (Minneapolis, MN; HS600C). CRP 
was measured with an R&D systems human high sensitivity reagent set (Minneapolis, MN, 
DCRP00). Interleukin-10 (IL-10) was measured using a Quantikine Human IL-10 ELISA 
immunoassay (R&D Systems; D1000B). TNF-α was measured using a Quantikine Human TNF-
α ELISA immunoassay R&D Systems (Minneapolis, MN; DTA00D). Detection ranges, as well as 
intra- and inter-assay coefficients of variation for each assay are presented in Table 1. Standard 
procedures for phlebotomy and specimen processing/storage were conducted at both time points. 
2.3.4 Covariates 
Demographics (age, education, race/ethnicity) were self-reported at baseline. Education 
was evaluated as highest degree attained and was categorized into high school and/or some college 
or vocational school or college degree or higher. Due to small cell sizes of non-white ethnicities 
(African American, Hispanic, Asian American), race was coded as white or non-white. Height and 
weight were measured via a fixed stadiometer and a balance beam scale. BMI was calculated 
(kg/m²). Non-steroidal anti-inflammatory medication usage was documented during the medical 
history interview. Depressive symptoms, alcohol use, physical activity, and menopause status were 
self-reported via questionnaires. Depressive symptoms were determined via the Center for 
Epidemiological Studies Depression Scale (CES-D).83 Possible scores on the CES-D ranged from 
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0-60 with higher scores representing greater symptomatology. Alcohol use was determined via 
self-report and was categorized as less than one drink per month or greater than one drink per 
month. Physical activity levels were determined using the International Physical Activity 
Questionnaire (IPAQ) and were scored as minutes of physical activity.84 Menopause status was 
determined from self-reported bleeding patterns over the year preceding the visit and was 
categorized as peri-menopausal or post-menopause using Stages of Reproductive Aging Workshop 
+10 criteria.85 
2.4 Statistical Analysis Plan 
Descriptive statistics, distributions, missing values, and outliers were examined for 
covariates, predictor variables, and outcome variables. Individuals with CRP values > 10 mg/L, 
extreme immune value outliers, or with inflammatory medical conditions or taking 
immunosuppressive medications were excluded. Immune values were log transformed to conform 
to model assumptions of normality. Chi-square analyses and t tests were conducted to determine 
if women missing childhood maltreatment, lifetime trauma, or inflammation data, or women 
excluded based on inflammatory medical conditions or taking immunosuppressive medications 
differed systematically from women with complete records. Multiple regression analyses testing 
independent as well as interactive effects of child and lifetime trauma in relation to inflammation 
controlling for age, race/ethnicity, education, BMI, and non-steroidal anti-inflammatory 
medication were conducted. Each inflammatory marker was considered separately. Childhood 
maltreatment was assessed at baseline and lifetime traumatic experiences were assessed at both 
time points. For analyses of change in inflammation, we considered cumulative lifetime trauma 
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exposure between the two visits. Covariates age, race/ethnicity, education, BMI, and non-steroidal 
anti-inflammatory drug use were selected based on known associations with both inflammation 
and childhood maltreatment.32,49,51,52,86 Covariates alcohol use, physical activity, depressive 
symptoms, and menopause status have proposed associations with inflammation and were 
considered as additional covariates in secondary analyses.32,52 Analyses were performed with R 
studio version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria). Models were two-
sided with α=.05. 
We tested aim 1 using multiple linear regression to evaluate cross-sectional associations 
between any instance of childhood maltreatment and levels of circulating markers of inflammation 
at both baseline and follow-up. Associations between any instance of childhood maltreatment and 
change in markers of inflammation over time were also assessed. We tested aim 2 using multiple 
linear regression to evaluate cross-sectional associations between any lifetime traumatic 
experience and levels of circulating markers of inflammation at baseline and follow-up. 
Associations between any lifetime traumatic experience and change in markers of inflammation 
over time were also assessed. We tested aim 3 using multiple linear regression to evaluate the 
relationship between childhood maltreatment, lifetime trauma, and inflammation. To test the stress 
accumulation model, both childhood maltreatment and lifetime traumatic experiences were 
included in the same model. Independent associations between child maltreatment and 
inflammation as well as lifetime trauma and inflammation were considered as support for the stress 
accumulation model. To examine the early life stress sensitization model, multiple linear 
regression was conducted to evaluate the interaction term between childhood maltreatment and 
lifetime traumatic experiences in relation to inflammation cross sectionally as well as to change in 
inflammation over time. A significant interaction in which the association between traumatic life 
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events and higher levels of as well as greater increases in inflammation over time was most 
pronounced among individuals with a history of childhood maltreatment was considered support 
for the early life stress sensitization model. To test the stress generation model, tests for mediation 
were conducted by calculating indirect effect of lifetime trauma in the relationship between child 
maltreatment and inflammation, which describes the proportion of the association between child 
maltreatment and inflammation that is explained by lifetime trauma. Although there are multiple 
methods for assessing the indirect effect (i.e. causal steps strategy, product of coefficients, 
distribution of the product),87,88 bootstrapping was utilized as it demonstrates higher power while 
maintaining reasonable control over the Type I error rate.89,90  
For all models in Aims 1-3, change in markers of inflammation over time were evaluated 
by examining levels of inflammation at follow-up while adjusting for baseline levels of 
inflammation. Although there is no universal approach for examining change over two time points, 
analyzing follow-up scores while including baseline scores as a predictor empirically fits a 
regression coefficient to the relationship between baseline and follow-up scores.91 Immune 
markers were considered separately in all models. To evaluate the exploratory aim, separate 
multiple linear regression models were performed to examine whether specific subtypes of 
maltreatment (sexual, physical, emotional abuse, physical and/or emotional neglect) or lifetime 
traumatic events (serious accident, natural disaster, serious illness, being attacked, unwanted 
sexual contact, death of a child, sexual harassment) were related to markers of inflammation. Each 
subtype of trauma was considered separately. Multiple linear regression was conducted to examine 
whether childhood maltreatment, lifetime traumatic experiences, or the relationship between 
childhood maltreatment and lifetime traumatic experiences were related to markers IL-10 and 




At baseline, participants were on average 54 years old, white, overweight, and had attained 
a college education or higher. See Table 2. Approximately a quarter of women (n=63) identified 
as African American. One hundred thirty-two women (44% of the sample) reported some form of 
abuse or neglect; emotional abuse (24%) was the most common form of abuse/neglect. One 
hundred seventy-eight women (60% of the sample) reported some form of lifetime trauma; 
unwanted sexual contact (21%) was the most common form of lifetime trauma. See Table 3. 
Women who returned for the follow-up visit 5 years later (N=170) did not differ from the original 
sample on key study variables such as age, race/ethnicity, education, BMI, immune medication 
usage, history of abuse/neglect, or history of lifetime trauma (p’s>.05). 
Women with less than a college education and non-white women were more likely to report 
childhood abuse/neglect.92 Women with a history of childhood abuse/neglect were more likely to 
report a experiencing a lifetime traumatic event and on average had higher depressive 
symptomatology. See Table 4. Levels of inflammatory markers and average BMI were comparable 
to those reported in a similar sample of midlife women.93 See Table 5. There was a significant 
positive association between CRP measured at baseline and follow-up [ρ= .77, p<.01], as well as 
IL6 measured at baseline and follow-up [ρ= .67, p<.01]. 
At baseline, a history of any instance of childhood abuse or neglect was not significantly 
associated with CRP or IL-6. See Table 6. In considering subscales, a history of childhood 
emotional abuse or physical neglect was associated with higher levels of IL-6, with associations 
persisting controlling for covariates. At baseline, neither a history of any instance of lifetime 
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trauma nor specific traumatic experiences were significantly associated with CRP or IL-6. See 
Table 7.  
At follow-up, neither a history of any instance of childhood abuse/neglect nor specific 
types of child abuse or neglect were significantly associated with CRP, IL-6, TNF-α, or IL-10. At 
follow-up, a history of any instance of lifetime trauma was not significantly associated with 
inflammatory markers. However, a history of being in a natural disaster was associated with higher 
levels of CRP, while a history of being physically attacked was associated with lower levels of 
TNF- α. See Table 7. Associations persisted controlling for covariates.  
In longitudinal analyses, neither a history of any instance of childhood abuse/neglect nor 
specific types of abuse or neglect were associated with change in levels of inflammatory markers 
over 5 years. See Table 6. A history of any instance of a lifetime traumatic experience was not 
associated with change in levels of inflammatory markers over 5 years. See Table 7. In considering 
specific traumatic experiences, a history of being in a natural disaster was associated with a greater 
increase in IL-6 over time and experiencing the death of a child was associated with a greater 
increase in CRP over time. Associations persisted controlling for covariates.  
Potential associations between childhood abuse/neglect, lifetime trauma, and levels of 
inflammatory markers were examined. When considering any childhood abuse/neglect and any 
lifetime trauma in the same model, neither childhood abuse/neglect nor lifetime trauma were 
independently associated with levels of inflammatory markers at baseline, follow-up, or with 
change in levels of inflammatory markers over time. See Table 8. A history of any childhood 
abuse/neglect did not significantly modify the association between any lifetime traumatic event 
and levels of inflammation at baseline, follow-up, or change in levels of inflammatory markers 
over time. See Table 9. Although main effects of childhood abuse and inflammation and lifetime 
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trauma and inflammation were not observed, tests of mediation were conducted to investigate the 
stress generation model of the relationship between trauma over the lifespan and later 
inflammation. A history of any lifetime traumatic event did not mediate the relationship between 
a history of any childhood abuse/neglect and levels of inflammatory markers at baseline, follow-
up, or change in levels of inflammatory markers over time. 
We conducted several secondary analyses. Associations between childhood abuse/neglect 
or lifetime trauma and change in levels of inflammation over time was examined using a raw 
difference score (rather than predicting follow-up scores while controlling for baseline values), 
and conclusions were unchanged (data not shown). Second, we considered menopause status, 
levels of leisure time physical activity, alcohol consumption, and symptoms of depression as 
additional covariates in relations between childhood abuse/neglect or lifetime trauma and later 
levels of inflammation. Including symptoms of depression as an additional covariate changed the 
relationship between childhood physical neglect and baseline levels of IL-6 from significant to 
marginal [B(SE)=0.11 (0.06), p=.06], but all other conclusions were unchanged (data not shown). 
Lastly, we excluded individuals with TNF-α levels below the assay’s lower limit of detection 
(N=30) when examining the associations between trauma and later levels of inflammation. The 
relationship between being physically attacked and lower levels of TNF-α at follow-up changed 
from significant to marginal [B(SE)=-.16 (0.09), p=0.097]. All other conclusions were unchanged 




Among a well-characterized sample of midlife women who completed measurements of 
systemic levels of inflammation, 44% of the cohort reported a history of childhood abuse/neglect 
and 60% reported a history of a lifetime traumatic event. Neither overall exposure to childhood 
abuse/neglect nor lifetime traumatic experiences were related to circulating levels of inflammation, 
while individual subtypes of abuse/neglect and lifetime trauma were associated with inflammation. 
Specifically, at baseline, a history of childhood emotional abuse or physical neglect was associated 
with higher levels of IL-6. At follow-up, a history of experiencing a natural disaster was associated 
with higher levels of CRP, while a history of experiencing a physical attack was associated with 
lower levels of TNF-α. In longitudinal analyses, a history of experiencing the death of a child was 
associated with greater increases in CRP over time and a history of experiencing a natural disaster 
was associated with a greater increase in IL-6 over time. Given the lack of consistency in 
associations, these results must be interpreted with caution. Collectively they suggest that in this 
sample of midlife women, trauma throughout the lifespan was inconsistently associated with 
inflammation. 
These findings contribute to the literature on trauma over the lifespan and later adverse 
health outcomes. Similar to other studies of midlife and older adults, a history of abuse/neglect 
and lifetime trauma were common in this sample.2,36,63 While previous research indicates that 
childhood maltreatment is associated with heightened levels of inflammation measured later in life 
both cross sectionally and longitudinally,38–40 findings have also been mixed.37,62,94 Previous 
research has not consistently utilized standardized/validated measurements of childhood 
measurements,37,39 which may result in underestimates in certain subtypes of abuse.38 In addition, 
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studies examining childhood trauma and adult inflammation have not consistently excluded on 
acute infection, which may contribute to heterogeneity in findings.40 Research also indicates that 
experiencing a traumatic event in adulthood is associated with higher levels of levels of 
inflammation measured both cross sectionally and longitudinally, 56–58 although other studies have 
failed to find significant associations.95,96 Previous research has not consistently considered 
relevant confounders such as BMI or depressive symptoms55,58 and has focused on specific traumas 
such as sexual violence or death of a loved one.55,56,59 This study attempted to address these 
limitations in the literature by examining relationships between childhood abuse/neglect, lifetime 
traumatic experiences, and inflammation while utilizing validated measures of multiple types of 
adversity in a well-characterized, acute illness-free, longitudinal sample. Although associations 
between childhood abuse/neglect, lifetime trauma, and inflammation were observed both cross 
sectionally and longitudinally, associations were not consistent across time or subtype of trauma 
and suggest that in this sample there was not a clear association between trauma and inflammation. 
While previous research has found associations between childhood abuse/neglect or 
lifetime trauma and inflammation, less is known about how childhood maltreatment and lifetime 
trauma collectively relate to adult inflammation. The stress sensitization model of the relationship 
between childhood maltreatment, lifetime trauma, and inflammation proposes that childhood 
trauma may shape reactions to stressors later in life such that those with a history of childhood 
maltreatment will demonstrate amplified biological responses to later adverse life events. The 
stress generation model hypothesizes that childhood stress predisposes individuals to experience 
more stressful experiences later in life and that these later stressors account for health effects seen 
in adulthood. Finally, the stress accumulation model posits that childhood adversity and lifetime 
trauma have independent influences on inflammation. While previous research has found the most 
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support for the stress sensitization model,61,62 there has also been support for the stress generation65 
and stress accumulation models.71 Only one study has compared these three potential models of 
the relationship between childhood maltreatment, lifetime traumatic experiences, and 
inflammation in the same study,71 and to date no studies have examined these relationships 
longitudinally. Thus, the present study is notable for being one of the few studies that compares 
three proposed models of the relationship between childhood abuse/neglect, lifetime traumatic 
experiences, and inflammation in a well-characterized longitudinal sample. However, given the 
relatively few observed relationships between childhood abuse, lifetime trauma, and inflammation 
in this study, analyses did not find support for either the stress sensitization, stress generation, or 
stress accumulation models. 
In this study of midlife women, associations between childhood abuse/neglect, lifetime 
trauma, and inflammation were observed for specific subtypes of abuse/neglect or trauma and were 
not consistent across time. The relationship between maltreatment and IL-6 or CRP observed in 
the literature is small (IL6: Cohen’s d=.16, CRP: d=.20).40 In order to detect an effect of this 
magnitude, a sample size of over one thousand participants would be required. Thus, this study 
may have been underpowered to detect associations. While we observed relationships between 
emotional abuse and physical neglect and higher levels of IL6 at baseline, these associations did 
not persist at follow-up. Notably, the sample size at follow-up (N=170) was considerably smaller 
than that at baseline (N=307). As the effect sizes for associations between physical neglect (but 
not emotional abuse) with IL-6 were similar at both baseline (d=.211) and at follow-up (d=.18), 
the smaller sample size at follow-up may have limited the power to detect these associations at 
follow-up. Associations between physical neglect and IL-6 were also comparable to those reported 
in the broader literature. This study found that specific lifetime traumatic experiences, such as 
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being in a natural disaster or experiencing the death of a child, were associated with higher levels 
of inflammation at follow-up and with greater increases in inflammation over time. Previous 
research has found associations between experiencing a natural disaster or the loss of a child and 
later physical health,97–101 and experiencing the death of a child is considered an especially potent 
traumatic event compared to losing other loved ones.100,102,103 However, the lack of consistency in 
associations warrants interpreting observed relationships with caution. A history of being 
physically attacked was associated with lower levels of TNF-α at follow-up. To our knowledge, 
no previous study has reported an inverse relationship between trauma and TNF-α, and after 
excluding individuals who demonstrated TNF-α levels below the lower limit of detection, this 
relationship changed from significant to marginal. Thus, the reliability of the observed association 
between being physically attacked and lower levels of TNF-α is questionable and should be 
interpreted with caution.  
Several characteristics of the current study sample warrant consideration in interpreting the 
study results. It is noteworthy that the present midlife cohort excluded individuals who took SSRIs, 
SNRIs, insulin, or beta-blockers, individuals with a history of medical conditions such as heart 
disease or stroke, and smokers. As trauma is associated with increased risk for depression,51 
behavior changes such as smoking and a more sedentary lifestyle,1,86 and worse health,104,105 the 
current sample may represent a less acutely distressed and healthier population which could 
partially explain inconsistent associations between trauma and inflammation. Thus, this sample is 
distinct from other studies of midlife women that have found consistent associations between 
trauma and inflammation.36 
This study should be considered in light of several limitations. Childhood maltreatment 
was measured by retrospective self-report, which is prone to inaccuracies.41 The stress 
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sensitization model assumes childhood maltreatment occurred during a sensitive period in 
childhood, however, measures of childhood maltreatment in this study did not assess age of 
exposure. Further, lifetime trauma was assessed at two time points and demonstrated low 
consistency, independent of new events reported. Lifetime traumatic events were assessed by a 
checklist of events, while research suggests multiple questions about specific events yields greater 
reliability.41 Although a quarter of the sample was non-white, Asian and Hispanic women were 
under-represented, and men were not included. The sample size was approximately halved from 
baseline to follow-up, which limits the power to detect associations. Examining subscales of 
traumatic events increased the number of statistical tests, which heightened the probability of type 
1 error. Two visits prohibit more intensive longitudinal analyses such as examining trajectories in 
change over time. 
The present study had several strengths. It was conducted in a well-characterized sample 
of midlife women who underwent extensive measurements of abuse, lifetime trauma, 
inflammation, and relevant demographic, behavioral, psychological, and health covariates. This 
study utilized a well validated measure of childhood abuse/neglect. This is the first study to 
examine three proposed models of how traumas over the lifespan relate and/or interact to influence 
later inflammation longitudinally, which further advances the literature on the long-term sequelae 
of childhood abuse. In conclusion, this study found that childhood abuse/neglect and lifetime 
trauma were prevalent in this sample of midlife women. Although associations between adverse 
experiences throughout the lifespan and inflammation were not consistent in this sample, trauma 
should routinely be considered when examining women’s health at midlife. 
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Appendix A Figures 
 
Figure 1 Visual Representations of the Stress Sensitization, Stress Generation, and 
Stress Accumulation Models. 
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Appendix B Tables 
Table 1 Assay Detection Range and Intra- and Inter-Assay Coefficients of Variation 
  
Assay Detection Range 
Intra-assay coefficient of 
variation 
Inter-assay coefficient of 
variation 
MsHeart    
Hs-CRP 0.5-20 mg/L         5.5%         3.0% 
IL-6 0.15-10 pg/mL         9.1%         10.2% 
MsBrain    
Hs-CRP 0.78-125 mg/L         5.5%         6.5% 
IL-6 0.156-10 pg/mL         2.3%         9.9% 
IL-10 2.0-500 pg/mL         3.7%         6.9% 
TNF-α 2.6-1,000 pg/mL         2.6%         7.7% 
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Table 2 Sample Characteristics 
BMI = body mass index, SD= standard deviation 
  




Age, M (SD) 54.1 (4.0) 59.0 (4.1) 
Race, n (%)   
     White 218 (73) 105 (71) 
     African American, Hispanic, other 80 (27) 43 (29) 
BMI, M (SD) 28.9 (6.8) 29.6 (7.12) 
Education, n (%)   
     High school, vocational school 127 (43) 59 (40) 
     College education or higher 171 (57) 89 (60) 
Child abuse/neglect (yes), n (%) 132 (44) 62 (42) 
Lifetime trauma (yes), n (%) 178 (60) 95 (64) 
Non-steroidal anti-inflammatory medications, n (%) 48 (16) 42 (28) 
Physical activity (IPAQ), median (IQR) 450 (0, 1386) 486 (0, 1401) 
Depressive symptoms (CESD), median (IQR) 5 (2, 11) 6 (2, 11) 
Current alcohol use, n (%)   
     > 1 drink/month 172 (58) 86 (58) 
    < 1 drink/month 126 (42) 62 (42) 
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Either time point 
(N=145) 
Any childhood maltreatment 132 (44) 62 (42) 62 (43) 
     Physical abuse 60 (20) 30 (20) 30 (21) 
     Sexual abuse 38 (13) 19 (13) 19 (13) 
     Emotional abuse 72 (24) 34 (23) 34 (23) 
     Emotional neglect 52 (17) 26 (18) 26 (145) 
     Physical neglect 61 (20) 29 (20) 29 (20) 
Any lifetime trauma 178 (60) 95 (64) 101 (70) 
     Serious accident 53 (18) 28 (19) 34 (23) 
     Natural or human disaster 32 (11) 16 (11) 23 (16) 
     Serious or life-threatening illness 17 (6) 7 (5) 7 (5) 
     Physical attacks 56 (19) 17 (11) 29 (20) 
     Unwanted sexual contact 64 (21) 34 (23) 41 (28) 
     Death of a child 19 (6) 9 (6) 12 (8) 
     Sexual harassment 59 (20) 33 (22) 43 (30) 
     Any other situation 41 (14) 18 (12) 30 (21) 
     Witnessing a severe injury or death 65 (22) 32 (22) 43 (30) 
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Table 4 Characteristics of Women with a History of Abuse or Neglect Compared to Those Without That 






Age, M (SD) 54.3 (3.8) 53.8 (4.2) 
Race, n (%)   
     White 129 (80) 86 (65)** 
     African American, Hispanic, other 33 (20) 46 (35) 
BMI, M (SD) 28.7 (6.0) 29.3 (7.6) 
Education, n (%)   
     High school, vocational school 59 (36) 66 (50)* 
     College education or higher 103 (64) 66 (50) 
Lifetime trauma (yes), n (%) 82 (51) 94 (71)*** 
Non-steroidal anti-inflammatory medications, n (%) 25 (15) 23 (17) 
Physical activity, leisure time, IPAQ, median (IQR) 565.5 (99, 1484) 297 (0, 1049) 
Depressive symptoms (CESD), median (IQR) 4 (1.3, 8.8) 8 (3, 14)*** 
Current alcohol use, n (%)   
     > 1 drink/month 94 (58) 75 (57) 
    < 1 drink/month 68 (42) 57 (43) 
***p<.001, **p<.01, *p<.05, †p<0.10 












Change over time (N= 145) 
(5 years) 
Hs CRP (mg/L), median (IQR) 1.4 (0.7, 3.7) 1.6 (0.8, 4.9) 0.2 (-0.3, 1.1) 
IL-6 (pg/mL), median (IQR) 2.1 (0.9, 2.2) 1.5 (1.00, 2.7) 0.1 (-0.3, 0.6) 
TNF-α (pg/mL), median (IQR) ---- 4.1 (2.9, 5.4) ---- 
IL-10 (pg/mL), median (IQR) ---- 4.1 (3.2, 5.6) ---- 
IQR = interquartile range 
Note: Baseline values for women who returned for follow-up (n=148): HsCRP (mg/L), median 
(IQR) = 1.4 (0.7, 4.1); IL-6 (pg/mL), median (IQR) = 1.4 (0.9, 2.2)
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Table 6 Associations Between Child Abuse/Neglect and Inflammation 




Change over time (N=115-145) 
(5 years) 
 Hs CRP B (SE) IL-6 B (SE) Hs CRP B (SE) IL-6 B (SE) TNF-α B (SE) IL-10 B (SE) Hs CRP B (SE) IL-6 B (SE) 
Sexual Abuse -0.06 (0.08) 0.03 (0.07) -0.10 (0.12) -0.01 (0.09) 0.02 (0.10) -0.10 (0.10) -0.12 (0.11) -0.04 (0.09) 
Physical Abuse -0.04 (0.07) 0.07 (0.06) 0.09 (0.10) 0.04 (0.07) -0.06 (0.08) 0.08 (0.09) 0.07 (0.09) 0.02 (0.07) 
Emotional Abuse -0.03 (0.06) 0.12 (0.05)* -0.01 (0.09) 0.05 (0.07) 0.00 (0.08) 0.10 (0.09) 0.09 (0.09) 0.02 (0.07) 
Physical Neglect -0.06 (0.07) 0.12 (0.06)* 0.04 (0.10) 0.13 (0.08) † -0.12 (0.08) -0.02 (0.09) 0.10 (0.09) 0.11 (0.07) 
Emotional Neglect -0.06 (0.07) 0.07 (0.06) -0.01 (0.10) 0.03 (0.08) 0.00 (0.09) 0.15 (0.09) 0.01 (0.09) 0.02 (0.07) 
Any childhood 
abuse/neglect 
0.00 (0.06) 0.05 (0.05) 0.12 (0.08) 0.06 (0.06) -0.10 (0.07) 0.05 (0.07) 0.14 (0.08) † 0.03 (0.06) 
**p<.01, *p<.05, †p<0.10 
Note: Each type of abuse considered as presence versus absence according to Child Trauma Questionnaire clinical cut points 
Note: Immune values were log transformed 
Covariates for cross sectional models: age, race/ethnicity, education, body mass index (BMI), and immune medication; covariates for 
longitudinal models: baseline age, race/ethnicity, education, inflammatory marker level, average BMI, immune medication usage at 





Table 7 Associations Between Lifetime Trauma and Inflammation 




Change over time (N=115-145) 
(5 years) 
 Hs CRP B (SE) IL-6 B (SE) Hs CRP B (SE) IL-6 B (SE) TNF-α B (SE) IL-10 B (SE) Hs CRP B (SE) IL-6 B (SE) 
Serious accident 0.00 (0.07) -0.06 (0.06) 0.05 (0.10) -0.10 (0.07) -0.05 (0.08) -0.07 (0.09) -0.02 (0.08) -0.11 (0.06)† 
Natural disaster 0.09 (0.09) 0.03 (0.07) 0.29 (0.12)* 0.11 (0.09) -0.07 (0.10) 0.04 (0.11) 0.16 (0.09)† 0.19 (0.07)** 
Serious illness 0.02 (0.11) -0.05 (0.10) 0.00 (0.19) -0.08 (0.13) -0.09 (0.15) 0.02 (0.16) 0.05 (0.17) 0.00 (0.13) 
Physical attack 0.03 (0.07) 0.09 (0.06) 0.03 (0.13) 0.05 (0.09) -0.37 (0.10)** -0.04 (0.11) 0.00 (0.09) 0.04 (0.07) 
Unwanted sexual 
contact 
0.00 (0.06) 0.01 (0.05) -0.05 (0.10) 0.03 (0.07) -0.13 (0.08) -0.04 (0.09) 0.00 (0.08) 0.03 (0.06) 










Table 7 (continued) 
Sexual harassment 0.13 (0.07)† 0.04 (0.06) 0.05 (0.09) 0.10 (0.07) -0.10 (0.08) -0.01 (0.08) 0.10 (0.07) 0.04 (0.06) 
Any other threatening 
situation 
0.01 (0.08) 0.06 (0.06) 0.04 (0.12) 0.03 (0.09) -0.17 (0.10) † -0.08 (0.11) -0.07 (0.09) -0.02 (0.07) 
Witness any dangerous 
situation 
-0.01 (0.06) -0.06 (0.05) 0.08 (0.09) 0.02 (0.07) -0.10 (0.08) 0.01 (0.08) 0.03 (0.08) -0.06 (0.06) 
Any trauma 0.07 (0.05) 0.00 (0.05) 0.16 (0.08)† 0.07 (0.06) 0.00 (0.07) -0.01 (0.07) 0.08 (0.08) 0.06 (0.07) 
**p<.01, *p<.05, †p<0.10 
Note: Each type of trauma considered as presence versus absence according to Nurses’ Health Study life events questionnaire. Trauma 
was considered as presence versus absence at either time point in longitudinal analyses 
Note: Immune values were log transformed 
Covariates for cross sectional models: age, race/ethnicity, education, body mass index (BMI), immune medication; covariates for 
longitudinal models: baseline age, race/ethnicity, education, inflammatory marker level, average BMI, immune medication usage at 






Table 8 Independent Effects of Child Abuse/Neglect and Lifetime Trauma 
**p<.01, *p<.05, †p<0.10 
Note: Each type of abuse considered as presence versus absence according to Child Trauma Questionnaire clinical cut points. Each 
type of trauma considered as presence versus absence according to Nurses’ Health Study life events questionnaire. Trauma was 
considered as presence versus absence at either time point in longitudinal analyses 
Note: Immune values were log transformed 
Covariates for cross sectional models: age, race/ethnicity, education, body mass index (BMI), immune medication; covariates for 
longitudinal models: baseline age, race/ethnicity, education, inflammatory marker level, average BMI, immune medication usage at 
either time point, and time between visits 
  
 Baseline (N=276-298) Follow-up (N=129-148) Change over time (N=122-145) 
 Hs CRP B (SE) IL-6 B (SE) Hs CRP B (SE) IL-6 B (SE) TNF-α B (SE) IL-10 B (SE) Hs CRP B (SE) IL-6 B (SE) 
Any child abuse/neglect -0.08 (0.06) 0.06 (0.05) 0.08 (0.09) 0.04 (0.06) -0.11 (0.07) 0.05 (0.08) 0.13 (0.08)† 0.01 (0.06) 
Any trauma 0.07 (0.06) -0.01 (0.05) 0.14 (0.09) 0.07 (0.06) 0.02 (0.07) -0.02 (0.08) 0.06 (0.08) 0.05 (0.06) 
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Table 9 Interactions Between Child Abuse/Neglect and Lifetime Trauma 
**p<.01, *p<.05, †p<0.10 
Note: Each type of abuse considered as presence versus absence according to Child Trauma Questionnaire clinical cut points. Each 
type of trauma considered as presence versus absence according to Nurses’ Health Study life events questionnaire. Trauma was 
considered as presence versus absence at either time point in longitudinal analyses 
Note: Immune values were log transformed 
Covariates for cross sectional models: age, race/ethnicity, education, body mass index (BMI), immune medication; covariates for 
longitudinal models: baseline age, race/ethnicity, education, inflammatory marker level, average BMI, immune medication usage at 
either time point, and time between visits 
 




Change over time (N=122-145) 
(5 years) 
 Hs CRP B (SE) IL-6 B (SE) Hs CRP B (SE) IL-6 B (SE) TNF-α B (SE) IL-10 B (SE) Hs CRP B (SE) IL-6 B (SE) 
Any child abuse/neglect -0.05 (0.11) 0.00 (0.08) 0.12 (0.16) -0.11 (0.12) -0.06 (0.13) 0.24 (0.14)† 0.34 (0.16)* -0.07 (0.13) 
Any trauma 0.09 (0.08) -0.04 (0.06) 0.15 (0.11) 0.01 (0.08) 0.04 (0.09) 0.06 (0.09) 0.14 (0.10) 0.01 (0.08) 
Any abuse * any trauma -0.03 (0.13) 0.09 (0.10) -0.05 (0.19) 0.19 (0.14) -0.06 (0.15) -0.26 (0.16) -0.26 (0.18) 0.11 (0.14) 
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Appendix C Supplementary Materials 
 
Table 10 Spearman's Correlations for Baseline Study Variables (N=298) 
Variable CRP IL-6 Child abuse Lifetime trauma Age Education Race/ethnicity Immune medication 
1. CRP         
2. IL-6 0.59*        
3. Any childhood abuse/neglect -0.01 0.10†       
4. Any lifetime trauma 0.00 -0.01 0.21**      
5. Age 0.05 0.11† -0.04 -0.01     
6. Education -0.15* -0.19* -0.14* 0.09 0.06    
7. Race/ethnicity -0.13* -0.14* -0.16* -0.02 0.11† 0.26*   
8. Immune medication -0.01 -0.09 0.01 -0.03 -0.01 0.00 0.03  
9. BMI 0.68* 0.61* 0.00 -0.08 0.05 -0.28* -0.11† 0.02 
**p<.01, *p<.05, †p<0.10 





Table 11 Spearman’s Correlations for Follow-up Study Variables (N=148) 
**p<.01, *p<.05, †p<0.10 
BMI = body mass index 
Variable CRP IL-6 TNF-α IL-10 Child abuse Lifetime trauma Age Education Race/ethnicity Immune medication 
1. CRP           
2. IL-6 0.60*          
3. TNF-alpha 0.36* 0.44*         
4. IL-10 0.20* 0.13 0.39*        
5. Any childhood 
abuse/neglect 
0.02 0.11 -0.10 0.05       
6. Any lifetime trauma 0.07 0.05 -0.01 -0.1 0.27**      
7. Age 0.17* 0.15† 0.22* -0.01 -0.17* -0.07     
8. Education -0.08 -0.14† -0.09 -0.07 -0.19* 0.00 0.11    
9. Race/ethnicity -0.17* -0.16† 0.10 0.02 -0.18* 0.11 0.23* 0.36*   
10. Immune medication 0.10 0.04 0.04 0.01 0.09 -0.06 0.11 -0.04 0.07  
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